Market Insights
Professional Development Through Knowledge Sharing
Update in Immuno-Oncology: Multiplicity of Drug In-Licensing Opportunities to Expand Your Pipeline
This market update captures assets currently in development and recent partnering/in-licensing transactions which can catalyze development and improve valuation for companies.
Ophthalmology Market: Opportunity for Growth Remains
The ophthalmology market values innovation approaches, demonstrated by premiums paid for acquisition of first-in-class therapies and public market support of ophthalmology gene therapy companies.
Cell-based Therapies: A Maturing Market Poised for Growth
The cell-based therapy market will grow significantly, supported by recent clarity in the FDA pathway, improved clinical outcomes as well as market entry by big pharma.
Contact Us for More Information
Would you like to learn more about working with Outcome Capital or discuss your specific needs?
© Outcome Capital 2024. Member of Financial Industry Regulatory Authority (FINRA) and the Securities Investment Protection Corporation (SIPC). Check the background of this firm on FINRA’s BrokerCheck.
Business Continuity Plan | Privacy Policy | Regulation Best Interest
